Brittain Medical Reporting Limited

Unaudited Financial Statements for the Year Ended 31 January 2026

Page

Balance Sheet

1

FIXED ASSETS

2,773

2,251

CURRENT ASSETS

157,090

189,178

CREDITORS

Amounts falling due within one year

(68,585

)

(92,589

)

NET CURRENT ASSETS

88,505

96,589

TOTAL ASSETS LESS CURRENT LIABILITIES

91,278

98,840

CREDITORS

Amounts falling due after more than one year

-

(5,833

)

NET ASSETS

91,278

93,007

CAPITAL AND RESERVES

91,278

93,007

NOTES TO THE FINANCIAL STATEMENTS

1.	STATUTORY INFORMATION

Brittain Medical Reporting Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address are as below:

Registered number:

09963281

Registered office:

48 - 52 Penny Lane

Mossley Hill

Liverpool

Merseyside

L18 1DG

2.	AVERAGE NUMBER OF EMPLOYEES

The average number of employees during the year was 2 (2025 - 2 ) .

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 January 2026.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 January 2026 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the Board of Directors and authorised for issue on 9 October 2026 and were signed on its behalf by:

Dr A D Brittain-Dissont - Director